High-Tech Microscopy Enables Tailored Rheumatology Therapies

Applied Precision Medicine

29-Jan-2025 - Researchers at CeMM and the Medical University of Vienna have developed an innovative microscopy-based approach that could predict the best approved drug to treat individual rheumatoid arthritis patients using samples of their blood. Published in the Lancet group journal EBioMedicine, the study ...

Artificial intelligence could improve therapy for lymphoma

09-Mar-2023 - Hodgkin’s lymphoma, a type of lymph node cancer, requires chemotherapy and radiation therapy that can be very stressful for patients. A research group in Vienna is working on a method to predict the course of the disease with the help of artificial intelligence algorithms. This would facilitate a ...

Epigenetic analysis of aggressive brain tumors

30-Aug-2018 - Glioblastoma is a brain cancer with devastating prognosis. A new collaborative study by scientists from CeMM, MedUni Vienna and the Austrian Brain Tumor Registry network demonstrates how epigenetic analysis of tumor samples collected in routine clinical practice could be used to better classify ...

Many brain disorders are genetically linked

28-Aug-2018 - A global study conducted by the international "Brainstorm Consortium" has, for the first time, analysed the genome of 1.1 million patients with psychiatric and neurological disorders and has shown that certain brain disorders are genetically related. For example, there is a significant ...

Lithium drugs: no prescription residues in drinking water

20-Sep-2016 - Studies show that lithium contained in drinking water lowers suicide rates. This still holds true when taking account of drug residues of lithium prescriptions, as has been shown by a current study for Austria within the context of a project supported by the Austrian Science Fund FWF. Can it be ...

Cholesterol-lowering drug kills melanoma cells - If messenger substance is present

07-Jun-2016 - Special cholesterol-lowering drugs can hamper the growth of metastasising melanoma cells if the cellular messenger substance Interleukin-6 (IL-6) is present. This link was observed in a research project funded by the Austrian Science Fund FWF. In laboratory tests, statins (cholesterol-lowering ...

Mechanism of Parkinson's spread demonstrated

24-Sep-2014 - An international, interdisciplinary group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has demonstrated, through the use of a new antibody, how Parkinson's disease spreads from cell to cell in the human brain.Until now, this mechanism has ...

Prostate cancer: New predictive and therapeutic options with TRAIL

23-Sep-2010 - One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological ...

Allergies through ozone effects?

Ozone increases allergen load

25-Aug-2010 - Ozone affects pollen allergens: at ozone levels typical of photochemical smog, more allergens are formed in pollen. This connection has been demonstrated in the rye plant and is now being published in the Journal of Allergy Clinical Immunology. The project funded by the Austrian Science Fund FWF ...

Overcoming resistance: New Options for the treatment of ovarian cancer

14-Apr-2010 - Research on the development of a new therapeutic agent for the treatment of particularly aggressive ovarian cancer has produced some very promising initial findings. In laboratory tests, scientists have succeeded in reducing the resistance of the tumour cells to a natural resistance mechanism ...